Delphine BADINAND
MD
-
Onco-radiotherapist at the Timone Hospital
APHM
MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.
Cancerology is booming and immunotherapy represents the most promising approach. At the APHM we have been at the forefront of these therapeutic advances and as a radiotherapist, I’m developing new strategies combining radiotherapy and immunotherapy to reach the « abscopal effect ». MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.
#cliniqueHave a look on our testimonies
MI COMMUNITY
“Our immunotherapy antibodies are positioned at the crossroads of two immunology fields with high potential: the g9d2 T cells and a novel superfamily of immunomodulators, butyrophilins”
Pierre d’EPENOUX
Imcheck Therapeutics
MI COMMUNITY
Marseille Immunopôle (Marseille Immunology Center) has the potential to provide precious help to open new diagnostic and therapeutic pathways and to provide our patients with even more options.
Pascale TOMASINI
AP-HM, AMU
MI COMMUNITY
We and our patients are resolutely committed to the Marseille Immunopôle; patients no longer wish to be simple "providers of biological samples", but full participants in the research process.
Jean-Robert HARLÉ
AMU, AP-HM
MI COMMUNITY
Together, we pursue a simple goal: to better understand the alterations of energetic metabolism in pancreatic cancer cells
Alice CARRIER
AMU, IPC, CRCM
MI AND YOU Show
your commitment to MI
your commitment to MI